Clinical Trial Update: Ruxolitinib Combined With Ibrutinib in Chronic Lymphocytic Leukemia Patients [Phase 1, Phase 2]

View source ↗

Summary

This document provides an update on a Phase 1/2 clinical trial evaluating the combination of ruxolitinib and ibrutinib in patients with chronic lymphocytic leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Ibrutinib (ibrutinib)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1, Phase 2 | Status: UNKNOWN